Daiichi Sankyo Inc.
| Website: | http://www.daiichisankyo.com/ |
| Industry: | Healthcare / Health Services |
| Employees: | 10000+ |
| Revenue: | $11B+ |
Overview
Daiichi Sankyo is a global pharmaceutical company and the second largest pharmaceutical company in Japan. It achieved JPY 970 billion in revenue in 2010 and is currently ranked number 17 in world sales. Its headquarter is based in Tokyo. The company also owns the American biotechnology company Plexxikon, the German biotechnology company U3 and Ranbaxy Laboratories in India. Daiichi Sankyo is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S.Open Jobs (387)
-
Yorktown Heights, NYApr 24
-
Boston, MAApr 24
-
Tulsa, OKApr 24
-
Lewisville, TXApr 24
-
Racine, WIApr 24
-
Gurnee, ILApr 24
-
Princeton, NJApr 24
-
Massapequa, NYApr 24
-
Dallas, TXMay 14
-
Atlanta, GAApr 24
